Neuralstem grants Sumitomo's Summit Pharmaceuticals International Corp. subsidiary exclusive rights to seek a partner on Neuralstem's behalf for the development of NSI-189 in Japan

Neuralstem Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sumitomo Corp. Group

Japan / Tools, Services, and Manufacturing

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced